how does minimal residual disease (mrd) testing affect treatment decisions?
Published 6 years ago • 1.3K plays • Length 4:10Download video MP4
Download video MP3
Similar videos
-
2:28
what is minimal residual disease (mrd) and how can it help speed up new myeloma drug approvals?
-
3:44
what is mrd, or minimal residual disease?
-
5:49
is minimal residual disease (mrd) testing routinely recommended?
-
3:26
how valuable is minimal residual disease testing for myeloma patients?
-
3:21
is there a new highly sensitive blood test to detect minimal residual disease?
-
5:05
should minimal residual disease (mrd) testing be routinely performed?
-
4:44
minimal residual disease (mrd) | high impact topic (hit)
-
2:57
when is the optimal time to measure minimal residual disease (mrd) in myeloma patients?
-
5:15
is mrd testing routinely recommended for myeloma patients?
-
1:36
how is minimal residual disease (mrd) testing used in myeloma care?
-
4:01
if a myeloma patient has mrd-negative status, does that mean that patient is cured?
-
5:46
what is minimal residual disease (mrd) in myeloma?
-
4:53
clinical implications of loss of minimal residual disease (mrd) negativity in multiple myeloma
-
1:12:05
a practical approach to mrd: testing with clonoseq
-
1:26
mrd in myeloma: the fda perspective
-
3:18
what does it mean when a myeloma patient is mrd negative?
-
0:42
how might mrd testing affect treatment decisions?
-
48:14
faqs on minimal residual disease
-
3:10
the importance of mrd in multiple myeloma in guiding treatment decisions & access to therapies